本页面由Tiger Trade Technology Pte. Ltd.提供服务

GT Biopharma Inc.

6.65
-0.0350-0.52%
成交量:3.06万
成交额:20.90万
市值:1,199.01万
市盈率:-0.50
高:7.05
开:6.79
低:6.52
收:6.68
52周最高:28.75
52周最低:4.91
股本:180.44万
流通股本:174.19万
量比:1.14
换手率:1.76%
股息:- -
股息率:- -
每股收益(TTM):-13.2195
每股收益(LYR):-156.2099
净资产收益率:-113.52%
总资产收益率:-158.16%
市净率:3.36
市盈率(LYR):-0.04

数据加载中...

2025/04/14

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2025/04/04

重要事件披露

Form 8-K - Current report
2025/03/12

SEC问询函

Form CORRESP - Correspondence
2025/02/26

重要事件披露

Form 8-K - Current report
2025/02/21

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/07

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/01/27

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/01/27

重要事件披露

Form 8-K - Current report
2024/12/23

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/11/28

重要事件披露

Form 8-K - Current report
2024/11/21

重要事件披露

Form 8-K - Current report
2024/11/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/16

重要事件披露

Form 8-K - Current report
2024/08/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/27

SEC问询函

Form CORRESP - Correspondence
2024/06/27

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/06/27

重要事件披露

Form 8-K - Current report
2024/06/26

重要事件披露

Form 8-K - Current report
2024/06/20

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/06/07

重要事件披露

Form 8-K - Current report